DK1474110T3 - Capsule with novel conjugated carriers - Google Patents

Capsule with novel conjugated carriers

Info

Publication number
DK1474110T3
DK1474110T3 DK03739446T DK03739446T DK1474110T3 DK 1474110 T3 DK1474110 T3 DK 1474110T3 DK 03739446 T DK03739446 T DK 03739446T DK 03739446 T DK03739446 T DK 03739446T DK 1474110 T3 DK1474110 T3 DK 1474110T3
Authority
DK
Denmark
Prior art keywords
carrier
capsule
agent
depot
novel conjugated
Prior art date
Application number
DK03739446T
Other languages
Danish (da)
Inventor
Gabriele Reich
Berthold Koehler
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag filed Critical Gelita Ag
Application granted granted Critical
Publication of DK1474110T3 publication Critical patent/DK1474110T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Abstract

Disclosed are a depot medicament containing a pharmacological agent and a carrier, particularly a depot medicament to be administered parenterally, carrier materials for depot medicaments, and a method for producing said carrier materials. A set amount of an agent is released over time while the agent is preserved in its pharmacologically effective form. The carrier is produced by using a carrier material comprising a carrier polymer formed by a polypeptide and a biodegradable polyester which is covalently linked thereto.
DK03739446T 2002-02-16 2003-01-24 Capsule with novel conjugated carriers DK1474110T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10206517A DE10206517A1 (en) 2002-02-16 2002-02-16 Depot medicinal products, carrier materials for depot medicinal products and processes for their production
PCT/EP2003/000725 WO2003068192A1 (en) 2002-02-16 2003-01-24 Depot medicament, carrier materials for depot medicaments, and method for the production thereof

Publications (1)

Publication Number Publication Date
DK1474110T3 true DK1474110T3 (en) 2007-12-10

Family

ID=27674694

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03739446T DK1474110T3 (en) 2002-02-16 2003-01-24 Capsule with novel conjugated carriers

Country Status (17)

Country Link
EP (1) EP1474110B1 (en)
AT (1) ATE369123T1 (en)
AU (1) AU2003210181A1 (en)
BR (1) BR0307675A (en)
DE (2) DE10206517A1 (en)
DK (1) DK1474110T3 (en)
EA (1) EA006988B1 (en)
ES (1) ES2289304T3 (en)
HU (1) HUP0500119A3 (en)
IL (2) IL162868A0 (en)
MX (1) MXPA04006982A (en)
NO (1) NO20043860L (en)
NZ (1) NZ533103A (en)
PL (1) PL371785A1 (en)
PT (1) PT1474110E (en)
WO (1) WO2003068192A1 (en)
ZA (1) ZA200403979B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20060682A1 (en) * 2006-12-19 2008-06-20 Sicit Chemitech S P A NEW BIODEGRADABLE POLYMER DERIVATIVES
DE102007011606A1 (en) 2007-03-02 2008-09-04 Carl Freudenberg Kg Fiber-tangled structure useful as cell settling material, wound covering, medical implant and carriers for pharmaceutical active substance and for producing depot medicament, comprises fibers made of partially interlaced gelatin material

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
DK0814778T3 (en) * 1995-03-10 2001-09-17 Roche Diagnostics Gmbh Polypeptide-containing pharmaceutical administration forms in the form of microparticles and their method of preparation
DE19813174A1 (en) * 1998-03-25 1999-05-27 Schering Ag Gas-filled microparticles, used for administering biologically active substances
CA2370357C (en) * 1999-04-16 2007-04-10 Wm. Marsh Rice University Poly(propylene fumarate) cross linked with poly(ethylene glycol)

Also Published As

Publication number Publication date
WO2003068192A1 (en) 2003-08-21
EP1474110B1 (en) 2007-08-08
BR0307675A (en) 2005-01-11
ZA200403979B (en) 2004-11-29
PT1474110E (en) 2007-10-01
EA200401012A1 (en) 2005-04-28
HUP0500119A3 (en) 2008-04-28
ES2289304T3 (en) 2008-02-01
EP1474110A1 (en) 2004-11-10
ATE369123T1 (en) 2007-08-15
IL162868A (en) 2008-03-20
MXPA04006982A (en) 2004-11-10
DE10206517A1 (en) 2003-09-04
EA006988B1 (en) 2006-06-30
NO20043860L (en) 2004-09-15
DE50307874D1 (en) 2007-09-20
NZ533103A (en) 2007-04-27
IL162868A0 (en) 2005-11-20
HUP0500119A2 (en) 2005-07-28
AU2003210181A1 (en) 2003-09-04
PL371785A1 (en) 2005-06-27

Similar Documents

Publication Publication Date Title
DE60018600D1 (en) BIOACTIVE COMPOUND COMPOSITE FOR "TISSUE ENGINEERING"
YU37301A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
DE602005003343D1 (en) MEDICINAL PRODUCTS WITH HIDDEN TASTE IN BREAKING MULTIPARTICLES
AR107948A2 (en) PHARMACEUTICAL FORMULATIONS
HRP20080117A2 (en) Pharmaceutical composition for modified release insulin sensitiser
DE69602517D1 (en) BIODEGRADABLE AND COMPOSTABLE POLYMERS MADE FROM CONJUGATED SERVES LIKE ISOPRENE OR 2,3-DIMETHYL-1,3-BUTADIENE
IL173078A0 (en) Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form
ATE252601T1 (en) LONG-ACTING INSULINOTROPE PEPTIDES
EP2471555A3 (en) Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
BRPI0412798A (en) use of a combination of a vascular endothelial growth factor antagonist and an antiproliferative agent, method of inhibiting or reducing tumor growth, pharmaceutical composition, use of a combination of a vegf antagonist and a chemotherapeutic agent, and, article of manufacture
ATE427981T1 (en) THERMOPLASTIC COMPOSITION, PRODUCTION METHOD AND ARTICLES MADE THEREFROM
WO2004060405A3 (en) Tissue reactive compounds and compositions and uses thereof
MXPA03003473A (en) Methods of producing oxazolidinone compounds.
ATE330943T1 (en) PRODUCTION PROCESS OF HUPERZINE A AND THEIR ANALOGUES AND COMPOUNDS USEFUL THEREOF
DE60320661D1 (en) SYSTEM WITH CONTROLLED RELEASE OF BIOACTIVE ACTIVE SUBSTANCES
WO2001060412A3 (en) Modification of biopolymers for improved drug delivery
DE50206912D1 (en) METHOD FOR CONTINUOUS PRODUCTION AND COATING OF SBC-BASED SELF-CONTAINING MATERIALS WITH AT LEAST ONE PHARMACEUTICAL AGENT
DK1474110T3 (en) Capsule with novel conjugated carriers
DE60329093D1 (en) STETHOSCOPE
DE602005009734D1 (en) IAL AND THERMOPLASTIC OR ELASTOMER MATERIAL AND METHOD FOR PRODUCING THE ARTICLE
ATE326985T1 (en) LYOPHILIZED PHARMACEUTICAL COMPOSITION OF PROPOFOL
BRPI0408946A (en) biocompatible polymer conjugated biologically active material with 1: 1 complex, its preparation process and pharmaceutical composition comprising the same
ATE549036T1 (en) THYMOSINE ALPHA-1 PEPTIDE/POLYMER CONJUGATES
ES2149471T3 (en) COMPOSED WITH SODIUM STARCH GLYCOLATE AS SUPPORT MATERIAL AND PRODUCTS BASED ON SUCH A COMPOUND.
AR034142A1 (en) A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION